News Release 30-Sep-2024 Peer-Reviewed PublicationJohns Hopkins Medicine A blood test that uses artificial intelligence (AI) to detect cancer-related genetic changes and protein biomarkers could help screen women for early signs of ovarian cancer, according to a study by researchers at the Johns Hopkins Kimmel Cancer Center in collaboration with several other institutions in the United...
Tag: <span>Liquid biopsies</span>
Post
Putting liquid biopsies on solid ground: Cancer diagnosis from a milliliter of blood
by Weizmann Institute of Science Different patterns of epigenetic markers revealed by EPINUC on blood nucleosomes (bright-red dots) of a healthy person (left) and a colorectal cancer patient (right). Credit: Weizmann Institute of Science Blood tests—simple, noninvasive and economically feasible—promise to become the next major milestone in cancer diagnosis. However, most of these tests, dubbed...
Post
Liquid biopsies one step closer to entering the clinic to help guide breast cancer treatment
by Institute of Cancer Research Credit: Ahmad Ardity via Pixabay A simple blood test can identify specific genetic mutations in patients’ breast tumors to help guide their treatment and assess how likely patients are to relapse, a study shows. By allowing clinicians to better understand the genetic characteristics of individual breast cancers, the blood test can be used to...
Post
Liquid biopsies may aid diagnosis, treatment of bladder, nerve tumors
by Julia Evangelou Strait, Washington University School of Medicine Credit: Pixabay/CC0 Public Domain Blood and urine tests could lead to faster and less invasive methods to diagnose and monitor various types of tumors, new research indicates. Two studies led by Washington University School of Medicine in St. Louis describe the potential of liquid biopsies to identify and track...